Trump Announces 100% Tariff on Imported Generic Drugs from August 2028
UPSC / SSC current affairs note · Economy
Why in news
US President Donald Trump announced a 100% tariff on imported generic drugs, effective August 2028, aiming to boost domestic pharmaceutical manufacturing. This move could impact Indian generic drug exports, as India is a major supplier to the US market.
Background
The US is the largest market for Indian generic drugs, with Indian companies supplying about 40% of generic medicines in the US. The announcement comes amid ongoing trade tensions and US efforts to reduce reliance on foreign pharmaceutical production.
Key facts
US President Donald Trump announced 100% tariff on imported generic drugs from August 2028.
The tariff aims to onshore production of pharmaceutical products to the US.
India is a major exporter of generic drugs to the US, accounting for nearly 40% of US generic drug supply.
The move could increase drug prices in the US and affect Indian pharmaceutical companies' revenues.
The announcement was made on Tuesday (date not specified).
Prelims pointers
- 100% tariff on imported generic drugs
- Effective from August 2028
- US President: Donald Trump
- India's share of US generic drug market: ~40%
Mains angles
- Impact on Indian pharmaceutical exports and trade relations with US
- Global supply chain resilience and onshoring trends
- Implications for US healthcare costs and access to affordable medicines